decisionhealth Newsletters, Part B News - 2022 Issue 10 (October)
Settlements in Cardinal case a warning that ‘prebates’ are kickback traps
Subscribe or sign in to view the full article.
Article Overview
This article examines a high-profile anti-kickback case involving specialty drug distribution, group purchasing organizations, and settlements with provider groups. It explains why the arrangement drew federal attention, how compliance concerns can arise around vendor discounts and upfront payments, and why the matter is relevant to provider organizations, compliance teams, and health care counsel.
Why This Topic Matters
The piece highlights how procurement and discount arrangements in specialty drug purchasing can become compliance risks under federal fraud-and-abuse enforcement. It is useful for organizations evaluating vendor relationships, rebate structures, and anti-kickback exposure in drug purchasing contracts.
What You Will Learn
- How a specialty drug distribution arrangement became the subject of an anti-kickback lawsuit
- Why certain vendor payment structures can trigger compliance concerns
- How settlements and enforcement actions can affect provider groups
- What kinds of health care purchasing relationships may attract government scrutiny
Who Should Read This
- Health care compliance professionals
- Provider group administrators
- Health care attorneys
- Pharmacy and specialty drug procurement teams
- Revenue cycle and contracting staff
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com